149 related articles for article (PubMed ID: 34587353)
1. A pilot study evaluating the efficacy and safety of retinaldehyde-loaded niosomes against mild-to-moderate acne.
Kim J; Kim J; Lee YI; Suk J; Lee D; Lee JH
J Cosmet Dermatol; 2021 Nov; 20(11):3586-3592. PubMed ID: 34587353
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of topical 0.2% Myrtacine® and 4% vitamin PP for prevention and treatment of retinoid dermatitis in patients with mild to moderate acne.
Veraldi S; Giovene GL; Guerriero C; Bettoli V
G Ital Dermatol Venereol; 2012 Oct; 147(5):491-7. PubMed ID: 23007255
[TBL] [Abstract][Full Text] [Related]
3. Acne RA-1,2, a novel UV-selective face cream for patients with acne: Efficacy and tolerability results of a randomized, placebo-controlled clinical study.
Cestone E; Michelotti A; Zanoletti V; Zanardi A; Mantegazza R; Dossena M
J Cosmet Dermatol; 2017 Jun; 16(2):265-270. PubMed ID: 28133878
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with retinaldehyde (0.1%) glycolic acid (6%) and efectiose (0.1%) in mild to moderate acne vulgaris during the period of sun exposure--efficacy and skin tolerability.
Masini F; Ricci F; Fossati B; Frascione P; Capizzi R; De Waure C; Guerriero C
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2283-6. PubMed ID: 25219827
[TBL] [Abstract][Full Text] [Related]
5. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi.
Anadolu RY; Sen T; Tarimci N; Birol A; Erdem C
J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):416-21. PubMed ID: 15196153
[TBL] [Abstract][Full Text] [Related]
6. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris.
Morel P; Vienne MP; Beylot C; Bonérandi JJ; Dréno B; Lehucher-Ceyrac D; Slimani S; Dupuy P
Clin Exp Dermatol; 1999 Sep; 24(5):354-7. PubMed ID: 10564319
[TBL] [Abstract][Full Text] [Related]
8. Interest of the association retinaldehyde/glycolic acid in adult acne.
Dreno B; Castell A; Tsankov N; Lipozencic J; Serdaroglu S; Gutierrez V; Gadroy A; Merial-Kieny C; Mery S
J Eur Acad Dermatol Venereol; 2009 May; 23(5):529-32. PubMed ID: 19192015
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of 0.1% retinaldehyde/ 6% glycolic acid (diacneal) for mild to moderate acne vulgaris. A multicentre, double-blind, randomized, vehicle-controlled trial.
Poli F; Ribet V; Lauze C; Adhoute H; Morinet P
Dermatology; 2005; 210 Suppl 1():14-21. PubMed ID: 15724103
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne.
Blume-Peytavi U; Fowler J; Kemény L; Draelos Z; Cook-Bolden F; Dirschka T; Eichenfield L; Graeber M; Ahmad F; Alió Saenz A; Rich P; Tanghetti E
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):166-173. PubMed ID: 31306527
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a facial serum and a mask containing salicylic acid and lipohydroxy acid in acne management: A randomized controlled trial.
Li S; He X; Zhang Z; Zhang XS; Niu YG; Steel A; Wang HT
J Cosmet Dermatol; 2023 Sep; 22(9):2502-2511. PubMed ID: 36999489
[TBL] [Abstract][Full Text] [Related]
12. Topical retinoids in acne--an evidence-based overview.
Thielitz A; Abdel-Naser MB; Fluhr JW; Zouboulis CC; Gollnick H
J Dtsch Dermatol Ges; 2008 Dec; 6(12):1023-31. PubMed ID: 18479477
[TBL] [Abstract][Full Text] [Related]
13. Topical Retinoids in Acne Vulgaris: A Systematic Review.
Kolli SS; Pecone D; Pona A; Cline A; Feldman SR
Am J Clin Dermatol; 2019 Jun; 20(3):345-365. PubMed ID: 30674002
[TBL] [Abstract][Full Text] [Related]
14. Topical retinoids in acne vulgaris: update on efficacy and safety.
Thielitz A; Gollnick H
Am J Clin Dermatol; 2008; 9(6):369-81. PubMed ID: 18973403
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of topical spironolactone 5% cream in the treatment of acne: A pilot study.
Ayatollahi A; Samadi A; Bahmanjahromi A; Robati RM
Health Sci Rep; 2021 Sep; 4(3):e317. PubMed ID: 34250269
[TBL] [Abstract][Full Text] [Related]
16. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris.
Domínguez J; Hojyo MT; Celayo JL; Domínguez-Soto L; Teixeira F
Int J Dermatol; 1998 Jan; 37(1):54-5. PubMed ID: 9522243
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.
Harper JC; Baldwin H; Stein Gold L; Guenin E
J Drugs Dermatol; 2019 Nov; 18(11):1147-1154. PubMed ID: 31741360
[TBL] [Abstract][Full Text] [Related]
18. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
Stein Gold L; Pariser DM; Guenin E
J Drugs Dermatol; 2019 Dec; 18(12):1218-1225. PubMed ID: 31860209
[TBL] [Abstract][Full Text] [Related]
19. The treatment of acne with topical retinoids: one man's opinions.
Kligman AM
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S92-5. PubMed ID: 9204084
[TBL] [Abstract][Full Text] [Related]
20. A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing.
Chao CM; Lai WY; Wu BY; Chang HC; Huang WS; Chen YF
J Cosmet Sci; 2006; 57(2):95-105. PubMed ID: 16688374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
